¼±Åà - È­»ìǥŰ/¿£ÅÍŰ ´Ý±â - ESC

 
"Histamine Agonists"¿¡ ´ëÇÑ °Ë»ö °á°úÀÔ´Ï´Ù. °Ë»ö °á°ú º¸´Â µµÁß¿¡ Tab ۸¦ ´©¸£½Ã¸é °Ë»ö âÀÌ ¼±Åõ˴ϴÙ.
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ À¯»ç °Ë»ö °á°ú : 1 ÆäÀÌÁö: 1
¿µ¹® histamine ÇÑ±Û È÷½ºÅ¸¹Î
¼³¸í   
  È÷½ºÅ¸¹ÎÀ̶õ ºñ¸¸¼¼Æ÷°ú È£¿°±â±¸¶ó´Â ¼¼Æ÷¿¡ ¸¹ÀÌ Àִ ¹°Áú·Î½á ±â´ÉÀº ´ÙÀ½°ú °°´Ù. 1. ¸ð¼¼Ç÷°üÀÇ À̿ϰú Åõ°ú¼ºÀÇ Áõ°¡ 2. ³»Àå¿¡ ºÐÆ÷Çϴ ±ÙÀ°ÀÇ ¼öÃà 3. À§»êÀÇ ºÐºñÃËÁø 4. ½ÉÀå¹Úµ¿¼öÀÇ Áõ°¡
  
  È÷½ºÅ¸¹ÎÀÌ ºÐºñµÇ¾î ´Ù¸¥ ¼¼Æ÷¿¡ ¿µÇâÀ» ÁÖ¾î À§¿Í °°Àº ¿ªÇÒÀ» ÇÏ·Á¸é ¹Ýµå½Ã ¼¼Æ÷Ç¥¸é¿¡ Àִ È÷½ºÅ¸¹Î ¼ö¿ëü¿Í °áÇÕÀ» ÇÏ¿©¾ßÇÑ´Ù. ÀÌ È÷½ºÅ¸¹Î ¼ö¿ëü¿¡´Â µÎ °¡Áö°¡ ÀÖ´Ù. Çϳª´Â H1-¼ö¿ëü¶ó°í Çϴ °ÍÀε¥ ÀÌ ¼ö¿ëü´Â À§ÀÇ ÀÛ¿ëÁß¿¡¼­ 1, 2¹øÀÇ ÀÛ¿ëÀ» ¸Å°³ÇÑ´Ù. Áï H1-¼ö¿ëü¿¡ È÷½ºÅ¸¹ÎÀÌ ºÎÂøÇÒ ¶§¿¡ À§ÀÇ 1, 2¹ø°ú °°Àº ÀÛ¿ëÀÌ ÀϾ´Ù. ´Ù¸¥ Çϳª´Â H2-¼ö¿ëü¶ó°í Çϴ °ÍÀε¥ 3, 4¹øÀÇ ÀÛ¿ëÀ» ¸Å°³ÇÑ´Ù. ±×¸®°í ¾ÈƼÈ÷½ºÅ¸¹Îµµ °¢°¢ H1-¼ö¿ëü¿¡ ÀÛ¿ëÇϴ °ÍÀÌ ÀÖ°í, H2-¼ö¿ëü¿¡ ÀÛ¿ëÇϴ °ÍÀÌ ÀÖ´Ù.
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 4 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • histamine
    È÷½ºÅ¸¹Î
  • histamine receptor
    È÷½ºÅ¸¹Î¼ö¿ëü
  • histamine sensitizing factor
    È÷½ºÅ¸¹Î¹Î°¨ÀÎÀÚ
  • histamine test
    È÷½ºÅ¸¹Î°Ë»ç
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 1 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • histamine
    È÷½ºÅ¸¹Î
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 3 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • histamine sensitizing factor
    È÷½ºÅ¸¹Î¹Î°¨ÀÎÀÚ
  • histamine
    È÷½ºÅ¸¹Î
  • histamine receptor
    È÷½ºÅ¸¹Î¼ö¿ëü
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 10 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • Histamine receptors
    È÷½ºÅ¸¹Î¼ö¿ëü
  • histamine
    È÷½ºÅ¸¹Î
  • histamine acid phosphate
    È÷½ºÅ¸¹Î»ê¼ºÀλ꿰
  • histamine cephalalgia
    È÷½ºÅ¸¹ÎµÎÅë.
  • histamine headache
    È÷½ºÅ¸¹Î(¼º) µÎÅë.
  • histamine oxidase
    È÷½ºÅ¸¹Î¿Á½Ã´ÙÁ¦.
  • histamine phosphate
    ÀλêÈ÷½ºÅ¸¹Î.
  • histamine release test
    È÷½ºÅ¸¹ÎÀ¯¸®½ÃÇè
  • histamine sensitizing factor =HSF
    È÷½ºÅ¸¹Î°¨ÀÛÀÎÀÚ(¡­ÊïíÂì×í­).
  • histamine, anaphylaxis
    È÷½ºÅ¸¹Î, ¾Æ³ªÆÈ¶ô½Ã¼º
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 13 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • benzodiazepine receptor agonists(s)
    º¥Á¶´ÙÀ̾ÆÁ¦ÇÉ ¼ö¿ëü ÀÛ¿ëÁ¦
  • histamine
    È÷½ºÅ¸¹Î
  • histamine acid phosphate
    È÷½ºÅ¸¹Î»ê¼ºÀλ꿰
  • histamine brochia challenge testin
  • histamine cephalalgia
    È÷½ºÅ¸¹ÎµÎÅë.
  • histamine fish poisonig
  • histamine headache
    È÷½ºÅ¸¹Î(¼º) µÎÅë.
  • histamine oxidase
    È÷½ºÅ¸¹Î¿Á½Ã´ÙÁ¦.
  • histamine phosphate
    ÀλêÈ÷½ºÅ¸¹Î.
  • histamine release test
    È÷½ºÅ¸¹ÎÀ¯¸®½ÃÇè
  • histamine sensitizing factor =HSF
    È÷½ºÅ¸¹Î°¨ÀÛÀÎÀÚ(¡­ÊïíÂì×í­).
  • histamine, anaphylaxis
    È÷½ºÅ¸¹Î, ¾Æ³ªÆÈ¶ô½Ã¼º
  • leukocyte histamine release test
    ¹éÇ÷±¸È÷½ºÅ¸¹ÎºÐºñ½ÃÇè
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 1 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • histamine
    È÷½ºÅ¸¹Î
KI ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 1 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • histamine
    È÷½ºÅ¸¹Î
KMLE ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 1
AHT aggregation half time; antihyaluronidase titer; augmented histamine test; autogenous hamster tumor
H2 blockers histamine blockers
HA H antigen; Hakim-Adams [syndrome]; halothane anesthesia; Hartley [guinea pig]; headache; health alli...
HAP Handicapped Aid Program; Hazardous Air Pollutants [List]; hazardous air pollution; health alliance p...
HC hair cell; hairy cell; handicapped; head circumference; head compression; health care; healthy contr...
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 1
DA Dopamine agonists
GnRHa Gonadotrophin releasing hormone agonists
4-MH 4-methyl histamine
H Histamine
H2 Histamine
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü À¯»ç °Ë»ö °á°ú : 4 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
  • augmented histamine test
    °­È­ È÷½ºÅ¸¹Î Áõ°­ ½ÃÇè
    12½Ã°£ ´Ü½Ä ÈÄ¿¡ ÀÜ·ù À§ ³»¿ë¹°À» ÈíÃâ±â·Î »¡¾Æ³½ ÈÄ, 15ºÐ °£°ÝÀ¸·Î 1½Ã°£ µ¿¾È ±âÃÊ À§ ºÐºñ¾×À» äÃëÇÑ´Ù. äÃë¿Ï·á 30ºÐ Àü¿¡ Àû´ç·®ÀÇ Ç×È÷½ºÅ¸¹ÎÀ» ±ÙÀ° ³»¿¡ Åõ¿©ÇÑ´Ù. ±âÃÊ ºÐºñ äÃë°¡ ³¡³¯ ¶§ »ê¼º Àλê È÷½ºÅ¸¹ÎÀ» ÆÄÇÏÁÖ»çÇϰí, À§ ³»¿ë¹°À» 15ºÐ °£°ÝÀ¸·Î 1½Ã°£ µ¿¾È äÃëÇÑ´Ù. °¢ 15ºÐ°£ÀÇ Ç¥º»¹°¿¡ ´ëÇÑ ºÎÇÇ,
  • histamine
    È÷½ºÅ¸¹Î
    ¾Æ¹ÎÀÇ ÀÏÁ¾. È÷½ºÆ¼µòÀÇ Å»Åº¼Ò¿¡ ÀÇÇÏ¿© Çü¼ºµÇ°í ¸¹Àº µ¿¹°À̳ª ½Ä¹°ÀÇ Á¶Á÷, ƯÈ÷ ºñ¸¸ ¼¼Æ÷¿Í È£¿°±â¼º ¼¼Æ÷ÀÇ °ú¸³¿¡ Á¸ÀçÇÑ´Ù. Àû¾îµµ 3°¡ÁöÀÇ Áß¿ä ÀÛ¿ëÀ» °¡Áö°í ÀÖ´Ù.
  • histamine flare test
    È÷½ºÅ¸¹Î ¹ßÀû È®Àå ½ÃÇè
    ³ªº´°ú Æ÷Áø ÈÄ ½Å°æÅë¿¡ ´ëÇÑ ½ÃÇè. ¹ßÀûÀÌ ³ªÅ¸³ª¸é ¾ç¼º ¹ÝÀÀ.
  • histamine oxidase
    È÷½ºÅ¸¹Î ¿Á½Ã´ÙÁ¦
CancerWEB ¿µ¿µ ÀÇÇлçÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
adrenergic agonists Drugs that bind to and activate adrenergic receptors.
(12 Dec 1998)
adrenergic alpha-agonists Drugs that selectively bind to and activate alpha adrenergic receptors.
(12 Dec 1998)
adrenergic beta-agonists Drugs that selectively bind to and activate beta-adrenergic receptors.
(12 Dec 1998)
gaba agonists Drugs that bind to and activate gaba receptors (receptors, gaba).
(12 Dec 1998)
cholinergic agonists Drugs that bind to and activate cholinergic receptors.
(12 Dec 1998)
myeloablative agonists Agents that destroy bone marrow activity. They are used to prepare patients for bone marrow or stem cell transplantation.
(12 Dec 1998)
serotonin agonists Agents that have an affinity for serotonin receptors and are able to mimic the effects of serotonin by stimulating the physiologic activity at the cell receptors. These compounds are used as antidepressants, anxiolytics, and in the treatment of migraine.
(12 Dec 1998)
nicotinic agonists Drugs that bind to and activate nicotinic cholinergic receptors (receptors, nicotinic). Nicotinic agonists act at postganglionic nicotinic receptors, at neuroeffector junctions in the peripheral nervous system, and at nicotinic receptors in the central nervous system. Agents that function as neuromuscular depolarising blocking agents are included here because they activate nicotinic receptors, although they are used clinically to block nicotinic transmission.
(12 Dec 1998)
dopamine agonists Drugs that bind to and activate dopamine receptors.
(12 Dec 1998)
excitatory amino acid agonists Drugs that bind to and activate excitatory amino acid receptors.
(12 Dec 1998)
lhrh agonists Compounds that are similar to LHRH (luteinizing hormone-releasing hormone).
(12 Dec 1998)
augmented histamine test A test for maximal production of gastric acidity or anacidity; after preliminary administration of an antihistamine, histamine acid phosphate is injected subcutaneously in a dose of 0.04 mg/kg of body weight, followed by analysis of gastric contents.
Synonym: augmented histamine test.
(05 Mar 2000)
receptors, histamine Cell-surface proteins that bind histamine and trigger intracellular changes influencing the behaviour of cells. Histamine receptors are widespread in the central nervous system and in peripheral tissues. Three types have been recognised and designated h1, h2, and h3. They differ in pharmacology, distribution, and mode of action.
(12 Dec 1998)
receptors, histamine h1 A class of histamine receptors discriminated by their pharmacology and mode of action. most histamine h1 receptors operate through the inositol phosphate/diacylglycerol second messenger system. Among the many responses mediated by these receptors are smooth muscle contraction, increased vascular permeability, hormone release, and cerebral glyconeogenesis.
(12 Dec 1998)
receptors, histamine h2 A class of histamine receptors discriminated by their pharmacology and mode of action. Histamine h2 receptors act via g-proteins to stimulate adenylate cylase. Among the many responses mediated by these receptors are gastric acid secretion, smooth muscle relaxation, inotropic and chronotropic effects on heart muscle, and inhibition of lymphocyte function.
(12 Dec 1998)
MeSH(Medical Subject Headings) ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú : 1 ÆäÀÌÁö: 1
  • Histamine Agonists - »õâ Drugs that bind to and activate histamine receptors. Although they have been suggested for a variety of clinical applications histamine agonists have so far been more widely used in research than therapeutically.
    Synonyms : H1 Agonist, H1 Agonists, H2 Agonist, H2 Agonists, H3 Agonist, H3 Agonists, Histamine Agonist, Histamine H1 Agonist, Histamine H1 Receptor Agonist, Histamine H1 Receptor Agonists, Histamine H2 Agonist, Histamine H2 Receptor Agonist, Histamine H2 Receptor Agonists
ÇÑ¿µ/¿µÇÑ »çÀü À¯»ç °Ë»ö °á°ú : 1 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • histamine
    È÷½ºÅ¸¹Î(Ç÷¾Ð°­ÇÏ,À§¾× ÃËÁøÁ¦)
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
KMLE ¾àǰ/ÀǾàǰ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
KMLE ¾àǰ/ÀǾàǰ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
KMLE ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
ÀÇÇÐ³í¹® ¾àÀÚ(Pubmed/Entrez) °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
CancerWEB ¿µ¿µ ÀÇÇлçÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
MeSH(Medical Subject Headings) À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü ¸ÂÃã °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü À¯»ç °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ ¸ÂÃã °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 1
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ À¯»ç °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 1
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference ¸ÂÃã °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference À¯»ç °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition ¸ÂÃã °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition À¯»ç °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 1
KMLE À¥ ¿ë¾î ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
KMLE À¥ ¿ë¾î À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
ÇÑ¿µ/¿µÇÑ »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
WordNet ÀÏ¹Ý ¿µ¿µ »çÀü °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü ¸ÂÃã °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü À¯»ç °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 1
ÅëÇÕ°Ë»ö ¿Ï·á